Mostrar el registro sencillo del ítem

Artículo

dc.creatorRecacha, E.es
dc.creatorMachuca, J.es
dc.creatorGarcía Duque, A.es
dc.creatorDocobo Pérez, Fernandoes
dc.creatorBlázquez, J.es
dc.creatorDíaz Díaz, S.es
dc.creatorPascual Hernández, Álvaroes
dc.creatorRodríguez Martínez, José Manueles
dc.date.accessioned2023-01-11T15:20:57Z
dc.date.available2023-01-11T15:20:57Z
dc.date.issued2021-03-18
dc.identifier.citationRecacha, E., Machuca, J., García Duque, A., Docobo Pérez, F., Blázquez, J., Díaz Díaz, S.,...,Rodríguez Martínez, J.M. (2021). Synergistic Quinolone Sensitization by Targeting the recA SOS Response Gene and Oxidative Stress. Antimicrobial Agents and Chenoterapy, 65 (4), e02004-20. https://doi.org/10.1128/AAC.02004-20.
dc.identifier.issn0066-4804;1098-6596es
dc.identifier.urihttps://hdl.handle.net/11441/141187
dc.description.abstractSuppression of the recA SOS response gene and reactive oxygen species (ROS) overproduction have been shown, separately, to enhance fluoroquinolone activity and lethality. Their putative synergistic impact as a strategy to potentiate the efficacy of bactericidal antimicrobial agents such as fluoroquinolones is unknown. We generated Escherichia coli mutants that exhibited a suppressed ΔrecA gene in combination with inactivated ROS detoxification system genes (ΔsodA, ΔsodB, ΔkatG, ΔkatE, and ΔahpC) or inactivated oxidative stress regulator genes (ΔoxyR and ΔrpoS) to evaluate the interplay of both DNA repair and detoxification systems in drug response. Synergistic sensitization effects, ranging from 7.5- to 30-fold relative to the wild type, were observed with ciprofloxacin in double knockouts of recA and inactivated detoxification system genes. Compared to recA knockout, inactivation of an additional detoxification system gene reduced MIC values up to 8-fold. In growth curves, no growth was evident in mutants doubly deficient for recA gene and oxidative detoxification systems at subinhibitory concentrations of ciprofloxacin, in contrast to the recA-deficient strain. There was a marked reduction of viable bacteria in a short period of time when the recA gene and other detoxification system genes (katG, sodA, or ahpC) were inactivated (using absolute ciprofloxacin concentrations). At 4 h, a bactericidal effect of ciprofloxacin was observed for ΔkatG ΔrecA and ΔahpC ΔrecA double mutants compared to the single ΔrecA mutant (Δ3.4 log10 CFU/ml). Synergistic quinolone sensitization, by targeting the recA gene and oxidative detoxification stress systems, reinforces the role of both DNA repair systems and ROS in antibiotic-induced bacterial cell death, opening up a new pathway for antimicrobial sensitization.es
dc.formatapplication/pdfes
dc.format.extent11 p.es
dc.language.isoenges
dc.publisherAmerican Society for Microbiologyes
dc.relation.ispartofAntimicrobial Agents and Chenoterapy, 65 (4), e02004-20.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectresistance reversiones
dc.subjectquinoloneses
dc.subjectSOS responsees
dc.subjectrecAes
dc.subjectoxidative stresses
dc.subjectdetoxification systemses
dc.titleSynergistic Quinolone Sensitization by Targeting the recA SOS Response Gene and Oxidative Stresses
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Microbiologíaes
dc.relation.projectIDPI14/00940es
dc.relation.projectIDPI17/01501es
dc.relation.projectIDRD16/0016/0001es
dc.relation.projectIDRD16/0016/0009es
dc.relation.publisherversionhttps://journals.asm.org/doi/10.1128/AAC.02004-20es
dc.identifier.doi10.1128/AAC.02004-20es
dc.journaltitleAntimicrobial Agents and Chenoterapyes
dc.publication.volumen65es
dc.publication.issue4es
dc.publication.initialPagee02004-20es
dc.contributor.funderInstituto de Salud Carlos III PI14/00940, PI17/01501es
dc.contributor.funderRed Española de Investigación en Enfermedades Infecciosas RD16/0016/0001, RD16/0016/0009es

FicherosTamañoFormatoVerDescripción
Synergistic Quinolone Sensitization ...1.561MbIcon   [PDF] Ver/Abrir  
Supplemental material Synergistic ...728.0KbIcon   [PDF] Ver/Abrir   Supplemental material

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional